{{Rsnum
|rsid=1460163
|Chromosome=8
|position=79315213
|Orientation=plus
|GMAF=0.2466
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 17.3 | 82.7
| HCB | 12.5 | 52.9 | 34.6
| JPT | 19.5 | 54.9 | 25.7
| YRI | 8.8 | 40.1 | 51.0
| ASW | 3.5 | 33.3 | 63.2
| CHB | 12.5 | 52.9 | 34.6
| CHD | 16.7 | 48.1 | 35.2
| GIH | 3.0 | 35.6 | 61.4
| LWK | 8.2 | 39.1 | 52.7
| MEX | 3.5 | 28.1 | 68.4
| MKK | 7.1 | 34.2 | 58.7
| TSI | 2.9 | 22.5 | 74.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19081515
|Trait=Creutzfeldt-Jakob disease
|Title=Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study
|RiskAllele=A
|Pval=6E-8
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs1460163
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19081515; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. (Initial Sample Size: 117 CJD cases, 3,083 controls; Replication Sample Size: 506 sCJD cases, 28 iCJD cases, 151 Kuru cases, 125 Kuru-resistant cases, up to 1,137 controls); (Region: 8q21.13; Reported Gene(s): STMN2; Risk Allele: rs1460163-A); (p-value= 0.00000006).This variant is associated with Creutzfeldt-Jakob disease.
|Drugs=
|Drug Classes=
|Diseases=Creutzfeldt-Jakob Syndrome
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740187
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1460163
|overall_frequency_n=34
|overall_frequency_d=128
|overall_frequency=0.265625
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=32
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}